Frequency Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FREQ and buy or sell other stocks, ETFs, and their options commission-free!About FREQ
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.
CEORam Aiyar, PhD, MBA
CEORam Aiyar, PhD, MBA
Employees104
Employees104
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees104
Employees104
FREQ Key Statistics
Market cap564.91M
Market cap564.91M
Price-Earnings ratio-0.87
Price-Earnings ratio-0.87
Dividend yield—
Dividend yield—
Average volume464.82K
Average volume464.82K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$55.89
52 Week high$55.89
52 Week low$5.20
52 Week low$5.20
Stock Snapshot
With a market cap of 564.91M, Frequency Therapeutics(FREQ) trades at $60.11. The stock has a price-to-earnings ratio of -0.87.
Frequency Therapeutics(FREQ) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Frequency Therapeutics(FREQ) shares are trading with a volume of 0, against a daily average of 464.82K.
During the past year, Frequency Therapeutics(FREQ) stock moved between $5.20 at its lowest and $55.89 at its peak.
During the past year, Frequency Therapeutics(FREQ) stock moved between $5.20 at its lowest and $55.89 at its peak.
People also own
Based on the portfolios of people who own FREQ. This list is generated using Robinhood data, and it’s not a recommendation.